An interventional study of CanXida Remove (Formula RMV) and Placebo in Candida Systemic, Candida Albicans Infection and Candida Infection, sponsored by CanXida. Completed at 1 site in United States. Open to female participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2024-08-22.
Sponsored by CanXida · Not applicable, Interventional, and Other
This is a virtual, double-blind, two-arm, randomized, placebo-controlled clinical trial that will last 12 weeks. Participants will take the CanXida Remove Candida Cleansing Formula RMV or a placebo product daily and complete questionnaires at Baseline, Week 6, and Week 12. Candida microbiome testing will be conducted via stool sample at Baseline and Week 12.
The participants will all be blinded to the name of the test brand.
65 studies on the registry are indexed under Candidiasis, Invasive; 6 are open to participants now.
This study's enrollment of 60 is close to the median of 60 across 47 interventional studies indexed under Candidiasis, Invasive.
Browse Candidiasis, Invasive studies →This is the only study on the registry with CanXida as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Self-reported recurrent vaginal issues, including:
Exclusion Criteria:
All participants will adhere to the following treatment regime: Day 1-7: 1 tablet per day Day 8-22: 2 tablets per day Day 23- 84: 3 tablets per day The product should always be taken with the first meal of the day.
Dietary Supplement: CanXida Remove (Formula RMV)
All participants will adhere to the following treatment regime: Day 1-7: 1 tablet per day Day 8-22: 2 tablets per day Day 23- 84: 3 tablets per day The product should always be taken with the first meal of the day.
Other: Placebo
Supplement composed of a 12 ingredient anti-fungal, anti-bacterial \& anti-parasite formula.
Placebo product containing Dicalcium Phosphate, Magnesium Stearate, Stearic Acid, Croscarmellose Sodium, and Silica.
Changes in growth of candida in the gut. [Timeframe: Baseline to Week 12]
Measured via gut microbiome analysis. Participants will provide a stool sample for the analysis.
Time frame: 12 weeks
Changes in vaginal health symptoms. [Timeframe: Baseline to Week 12]
Measured via study-specific questionnaires. Questionnaires will use a Likert scale (0-5 scale) to measure changes in vaginal itching, vaginal discharge, vaginal discomfort. On the scale, 0= the least favourable score and 5= the most favourable score.
Time frame: 12 weeks
Changes in scores on the Gastrointestinal Symptom Rating Scale (GSRS). [Timeframe: Baseline to Week 12]
The GSRS is a disease-specific instrument of 15 items combined into five symptom clusters depicting Reflux, Abdominal pain, Indigestion, Diarrhoea and Constipation. The GSRS has a seven-point graded Likert-type scale where 1 represents absence of troublesome symptoms and 7 represents very troublesome symptoms.
Time frame: 12 weeks
Changes in scores on the Bristol Stool Scale. [Timeframe: Baseline to Week 12]
The Bristol Stool Scale is a scale that classifies stools, ranging from the hardest to the softest. Experts consider types 1 and 2 to be uncharacteristically hard and indicative of constipation, while types 6 and 7 are unusually loose and may indicate diarrhea. Medical professionals generally consider types 3, 4, and 5 to be the most typical.
Time frame: 12 weeks
Changes in self-reported energy levels. [Timeframe: Baseline to Week 12]
Measured via study-specific questionnaires using a 5-point Likert scale. 0= the most favourable and 5= the least favourable response.
Time frame: 12 weeks
Plan to share: Undecided
No publications or documents are linked to this record.
Ran from Nov 2023 to primary completion in Jun 2024, 6 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Aug 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.